therapeutic solutions international inc  company spotlight profile warning this site has features that require javascript watch therapeutic solutions international inc sector business services not elsewhere classified region ca united states   otc markets tsoi listed in consumer goods and services similar to hyrican informationssysteme ag systar sa ♣ request investor kit view contact details news  analysis featured company diodes inc dallas tx us diodes inc manufactures and sells semiconductor devices the company is engaged in the manufacturing and distribution of semiconductor products to you may also be interested in systar sa saintcloud if fr systar sa engages in the development and marketing of business activity monitoring for large businesses administrations and banks its product hyrican informationssysteme ag kindelbrück th de hyrican informationssysteme ag engages in the provision of information and communications technology services its activities include the distribution and sale silgan holdings inc stamford ct us headquartered in stamford connecticut silgan holdings inc is a leading manufacturer of rigid packaging for consumer goods products with annual × contact investor relations therapeutic solutions international inc investor relations  oceanside boulevard suite b oceanside  ca  united states phone sic code  close × request investor kit select your country afghanistan aland islands albania algeria american samoa andorra angola anguilla antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bonaire st eust saba bosnia and herzegovina botswana bouvet island brazil brit indian ocean terr british virgin islands brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo dem rep of the congo rep of cook islands costa rica croatia cuba curacao cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands faroe islands fiji finland france french guiana french polynesia french southern terr gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard  mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy ivory coast jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan la reunion laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marianas marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk island north korea norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar romania russian federation rwanda saint barthelemy saint helena saint kitts and nevis saint martin saint pierre  miquelon samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore sint marten slovakia slovenia so georgia  so sand isl solomon islands somalia south africa south korea spain sri lanka st vincent  grenadines st lucia sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand timorleste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying isl uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city venezuela vietnam virgin islands wallis  futuna western sahara yemen zambia zimbabwe email required field first name required field last name required field street  required field street  city required field stateprovince  alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming required field postal code required field i consent to receiving periodic email communications from therapeutic solutions international inc id like to receive more information from precisionir watch watch this company to be notified of upcoming earnings calls and new content with a weekly digest sent to your email watch content go cancel company spotlight is available free to investors through the financial support of participating companies in return for receiving this free information your contact data are made available to the companies whose reports you have ordered and to other parties as described in our privacy policy which you can read in its entirety here in addition you agree to be contacted by these companies from time to time you may select at any time to opt out of these communications by using the unsubscribe link in your emails or by sending an email to nacustomerserviceprecisionircom × enter your email address to watch this company email required required field first name last name signup × enter your email address and notification preferences a reminder has been added for this event add to calendar add to google calendar add to live calendar add to yahoo calendar add to icalender add to outlook calendar or send me a reminder weeks                                                      days        hours                         minutes                                                             before the event please enter a valid email to watch first name last name signup therapeutic solutions international inc private company information  bloomberg august    am et pharmaceuticals company overview of therapeutic solutions international inc snapshot people company overview therapeutic solutions international inc focuses on immune modulation for the treatment of various diseases the company develops a range of immunemodulatory agents to target various cancers enhance maternal and fetal health and fight periodontal disease as well as for daily health its flagship product is projuvenol a synergistic blend of antiaging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality the company also markets trx a testosterone booster nutraceutical vital female an estrogen booster nutraceutical and oncologist friendly nutraceuticals such as coenzyme q curcumin glutathione and vitaminc in oz bottles in liposome therapeutic solutions international inc focuses on immune modulation for the treatment of various diseases the company develops a range of immunemodulatory agents to target various cancers enhance maternal and fetal health and fight periodontal disease as well as for daily health its flagship product is projuvenol a synergistic blend of antiaging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality the company also markets trx a testosterone booster nutraceutical vital female an estrogen booster nutraceutical and oncologist friendly nutraceuticals such as coenzyme q curcumin glutathione and vitaminc in oz bottles in liposome formula in addition it focuses on developing clia dx and dxrx products and services for prepregnancy and pregnancyassociated conditions or diseases the company was founded in  and is based in oceanside california detailed description  oceanside boulevardsuite boceanside ca united statesfounded in  employees phone  wwwtherapeuticsolutionsintcom key executives for therapeutic solutions international inc mr timothy george dixon chairman chief executive officer  president age  total annual compensation k mr gerry b berg cfo vp secretary  director age  total annual compensation k compensation as of fiscal year  therapeutic solutions international inc key developments therapeutic solutions international inc auditor raises going concern doubt jun   therapeutic solutions international inc filed its k on jun   for the period ending dec   in this report its auditor squar milner llp  squar milner reehl  williamson llp gave an unqualified opinion expressing doubt that the company can continue as a going concern therapeutic solutions international inc announces the filing of new patent for biologic product called memorymune jun   therapeutic solutions international inc announced the filing of a new patent for a biologic product called memorymune the patent describes methods protocols and compositions of matter useful for stimulation of anticancer immune responses in one embodiment of the invention culturing of buffy coat cells is performed in an environment resembling nonphysiological conditions buffy coat derived products are subsequently harvested concentrated and added to a culture of monocytes and lymphocytes conditioned media from this second culture is subsequently utilized as an injectable solution for stimulation of anticancer immunity memorymune therefore is a product derived from a twostep culture process of donor blood cells memorymune is being developed with the purpose of reawakening dormant immune memory cells by mimicking a process called homeostatic immune expansion it is known that many cancer patients possess memory t cells that enter the tumor however once inside the tumor these cells are inactivated memorymune contains a unique combination of growth factors specific for immune system cells called cytokines therapeutic solutions international inc enters in to agreement with emvolio inc may   therapeutics solutions international inc announced an exclusive licensing agreement with its subsidiary emvolio inc the patent outlicensed to emvolio titled “activated leukocyte extract for repair of innate immunity in cancer patients” but clinically named innamune is also an important and complementary product to the company previously announced licensing of “stemvacs” and “cancer metabolic detox” to emvolio similar private companies by industry company name region st order pharmaceuticals inc united states st century animal health united states  buds organics llc united states p therapeutics llc united states ° pharmaceuticals llc united states recent private companies transactions typedate target private placement september    request profile update    the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact therapeutic solutions international inc please visit wwwtherapeuticsolutionsintcom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close therapeutic solutions international inc  select page therapeutic solutions international returns to fully reporting status with sec read more tsoi subsidiary sandbox dental labs files k with fda company seeks market clearance for oral appliance to treat moderate obstructive sleep apnea read more tsoi announces exclusive patent license agreement with subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies read more tsoi files patent on methods of reactivating dormant memory cells with anticancer activity company developing proprietary products that help immune system fight cancer read more tsoi announces exclusive patent license agreement with subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies read more tsoi files new patent on augmentation of antitumor immunity by mifepristone and analogues thereof company developing proprietary products that help immune system fight cancer read more tsoi announces exclusive patent license agreement to innamune with its subsidiary emvolio inc company developing proprietary products that help immune system fight cancer read more tsoi files patent on blood derived innate immune system stimulator company resurrecting “transfer factor” immunotherapeutic for treatment of cancer read more tsoi announces exclusive patent license agreement with its subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies read more tsoi files new patent on targeting the tumor microenvironment through nutraceutical based immunoadjuvants company developing proprietary nutraceutical products that help modulate immune system read more tsoi announces appointment of dr thomas e ichim to its subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies read more sandbox dental labs inc – is a majority owned subsidiary of tsi consisting of a dental laboratory to manufacture and fill prescriptions from dentists who will use our proprietary sleep appliance to treat their patients with mild to moderate obstructive sleep apnea emvolio inc – is a majority owned subsidiary of tsi where the intellectual property surrounding immuneoncology is housed  the company is developing products that can be used together to attack cancer at different levels as well as to be used alone or in combination with existing therapies omnibiome inc – is a majority owned subsidiary of tsi where the intellectual property surrounding probiotics is housed current programs focus on the use of probiotics to prevent preterm labor and on using probiotics to reverse periodontal disease nutraceutical division – tsi has been producing very high quality nutraceuticals its flagship product projuvenol® is a patented no  proprietary mixture containing pterostilbene – one of the most potent antioxidants known welcome to therapeutic solutions international inc  inspired by nature  designed to rejuvenate  item hello guest featured products coq liposomal oz your price  this product is now available curcumin liposomal oz your price  this product is now available glutathione liposomal oz your price  this product will ship when available projuvenol  capsule your price   money back guarantee free shipping trx  capsule your price   money back guarantee free shipping vital  capsule your price   money back guarantee free shipping vitaminc liposomal oz your price  this product is now available    quick view therapeutic solutions international inc announces definitive agreement with ss uk limitedhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  hrs  minssp  dow  nasdaq therapeutic solutions international inc announces definitive agreement with ss uk limitedmarketwiredjune  reblogsharetweetshareoceanside camarketwired  jun    therapeutic solutions international inc  otcqb  tsoi  announced today the signing of a distribution agreement with ss uk limited for exclusive distribution rights in the united states to market the us patented and fda cleared titratable sleep appliance hardware sold under the trademark sleepwell™today was a major achievement and milestone for ss and our ever popular sleepwell™ appliance which has been so successful in europe stated matt everatt technical director of ss uk limited our signing of this agreement with tsi to exclusively distribute the sleepwell appliance hardware will give us dentists a new product that can help individuals suffering from snoring and sleep apneadr barry glassman vp of education and training of therapeutic solutions international stated this proven technology is a very attractive choice for both the dentist providing oral appliance therapy and for the patient seeking an alternative treatment for sleep disturbed breathing compared to the traditional therapies including surgery and cpapwe at tsi are excited about bringing this quality yet cost effective appliance choice to the united states said ceo tim dixon of therapeutic solutions international who added according to the us department of health and human services the prevalence of sleep apnea in the us population is similar to asthma  million patients and diabetes  million patients we look forward to working with dentists and dental laboratories in bringing this product to the patientsleepwell™ components are used to manufacture the appliance in a dental laboratory using a bilaminate material customized to the patients teeth with a special soft inner lining for maximum comfort and retention the appliance also incorporates a specially designed component made from medical grade  stainless steel which ensures that the lower jaw is held in a forward position while permitting the wearer sidetoside movement during sleep therapeutic solutions international is also a global manufacturer of the chairside anterior midpoint stop appliance ampsa devices marketed internationally under the trade names migranx® and ampsa cs® which have helped countless patients prevent debilitating migraine and tension headache pain bruxism clenching grinding and tmj disorders the migranx® and ampsa cs® devices are the most effective nondrug us fda cleared dental method of migraine prevention on the market todayabout therapeutic solutions international incthe companys corporate website is wwwtherapeuticsolutionsintcom nonus dentists and physicians can order our ampsa products at wwwordertsoicom for the sleepwell™ product clinical data can be viewed at wwwsleepwelldevicecomsafe harbor statement this release contains forwardlooking statements that are based upon current expectations or beliefs as well as a number of assumptions about future events although we believe that the expectations reflected in the forwardlooking statements and the assumptions upon which they are based are reasonable we can give no assurance that such expectations and assumptions will prove to have been correct forwardlooking statements are generally identifiable by the use of words like may will should could expect anticipate estimate believe intend or project or the negative of these words or other variations on these words or comparable terminology the reader is cautioned not to put undue reliance on these forwardlooking statements as these statements are subject to numerous risk factors as set forth in our sec filings to the extent that statements in this press release are not strictly historical including statements as to product launch timing revenue projections business strategy outlook objectives future milestones plans intentions goals future collaboration agreements or otherwise as to future events such statements are forwardlooking and are made pursuant to the safe harbor provisions of the private securities litigation reform act of  the forwardlooking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made readers are advised to review our filings with the securities and exchange commission that can be accessed over the internet at the secs website located at wwwsecgovreblogsharetweetsharerecently viewedyour list is emptywhat to read next people have canceled their tesla model  ordersbusiness insiderthe ultimate app for roadtrip wanderlustus banksponsoreddont put that guy in front of the cameras again fox news host unloads on stephen miller after altercation with cnn reporterbusiness insiderthat doesnt just happen trump continues to boast about the stock marketyahoo financeif you want to lose weight this is how to structure your workoutpopsugar usstart living the millionaire lifestyletoroptionsponsoredmy fear is the us economy gets stuck in a low growth trap nyse traderyahoo finance videotesla delivers the spark investors wantedyahoo financethese are the greatest fears that people have in the worldbusiness insidera british volunteer fighting isis in syria reportedly killed himself to avoid being capturedbusiness insider of android users are less likely to switch to iphone due to headphone jackyahoo financeoprah winfrey keeps it real on weight loss explains why she cant accept herself weighing over  poundsentertainment tonightstocks are facing these headwinds at dow k nyse traderyahoo finance videohow to get one of the  jobs at amazonyahoo financefoxconn steers clear of trumps  billion investment claimassociated pressafter trying to build selfdriving tractors for more than  years john deere has learned a hard truth about autonomyquartztrump set to embark on st vacation since inaugurationbill trump has played  rounds of golf already sounds like hes been on vacation since he took officejoin the conversation  k therapeutic solutions international inc    facebook facebook？online store      oceanside blvd ste b youcanordernowcom  pure encapsulations／city of oceanside economic developmentbrenda loves sharingtherapeutic solutions international inc · english us · español · português brasil · français france ·  ·  · ad choices · cookie ·  facebook   trxanimation  cancer moonshot  from nanthealth llctherapeutic solutions international inc ·   · july    et therapeutic solutions international returns to fully reporting status with sec oceanside camarketwired  july    therapeutic solutions international inc otc pink tsoi announced today that it has recently completed all of its regulatory filings to return to fully reporting status required by the securities and exchange commission sec⋯⋯therapeutic solutions international inc ·  · june    et therapeutic solutions subsidiary sandbox dental labs files k with fda company seeks market clearance for oral appliance to treat moderate obstructive sleep apnea⋯⋯therapeutic solutions international inc ·  · june    et therapeutic solutions international announces exclusive patent license agreement with subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies⋯⋯therapeutic solutions international inc ·  · june    et therapeutic solutions files patent on methods of reactivating dormant memory cells with anticancer activity company developing proprietary products that help immune system fight cancer⋯⋯therapeutic solutions international inc ·  · june    et therapeutic solutions international announces exclusive patent license agreement with subsidiary emvolio inc emvolio is developing products that can be used together to attack cancer at different levels as well as be used alone or in combination with existing therapies⋯⋯therapeutic solutions international inc ·  · may    et therapeutic solutions files new patent on augmentation of antitumor immunity by mifepristone and analogues thereof company developing proprietary products that help immune system fight cancer⋯⋯therapeutic solutions international inc ·  · may    et therapeutic solutions international announces exclusive patent license agreement to innamune with its subsidiary emvolio inc company developing proprietary products that help immune system fight cancer⋯⋯therapeutic solutions international inchas been producing high quality nutraceuticals it’s flagship product projuvenol is a proprietary mixture containing pterostilbene – one of the most potent antioxidants knowntherapeuticsolutionsintcomtherapeutic solutions international inc ·  · therapeutic solutions files patent on blood derived innate immune system stimulator company resurrecting transfer factor immunotherapeutic for treatment of cancer oceanside camarketwired  may    therapeutics solutions international inc otc pink tsoi announced today the filing of a patent for a novel blood derived stimulator of innate immune cells called innamune⋯⋯therapeutic solutions international inc   。 ·  · therapeutic solutions international announces exclusive patent license agreement with its subsidiary emvolio incoceanside camarketwired  may    therapeutics solutions international inc otc pink tsoi announced today an exclusive licensing agreement with its subsidiary emvolio inc the patent outlicensed today to emvolio titled targeting the tumor microenvironment through nutraceutical bmarketwiredcomtherapeutic solutions international inc   。 ·  · therapeutic solutions files new patent on targeting the tumor microenvironment through nutraceutical based immunoadjuvantsoceanside camarketwired  may    therapeutics solutions international inc otc pink tsoi announced today the filing of a patent for a nutraceutical product called cancer metabolic detoxcancer metabolic detox is an orally administered all natural nutraceutical product that is commarketwiredcomtherapeutic solutions international inc   。 ·  · therapeutic solutions international announces appointment of dr thomas e ichim to its subsidiary emvolio incoceanside camarketwired  may    therapeutics solutions international inc otc pink tsoi announced today that the board of directors of its majority owned subsidiary emvolio inc emvolio has appointed thomas e ichim phd as chief executive officer of emvoliodr ichim is a semarketwiredcomtherapeutic solutions international inc ·  · april    et therapeutic solutions internationals subsidiary omnibiome inc announces first oral microbiome therapy for periodontal disease company files patent and obtains proof of concept data on late david palellas vision of scientifically driven microbiome modulatory consumer products⋯⋯therapeutic solutions international inc ·  · we are so happy to announce the filing of our an ind with the us fda for stemvacs our new cancer vaccinetherapeutic solutions internationals subsidiary emvolio inc files investigational new drug application for stemvacs cancer immunotherapyoceanside camarketwired  april    therapeutics solutions international inc otc pink tsoi announced today the filing of an investigational new drug ind application by its majority owned subsidiary emvolio inc for use of its stemvacs cancer immunotherapeutic in patients with…marketwiredcomtherapeutic solutions international inc ·  · therapeutic solutions international announces filing of new immunotherapy patent and exclusive patent license agreement with subsidiary emvolio inc cancer tumor patent centuryhttpwwwmarketwiredcompressreleasetherapeuticsolutionsinternationalannouncesfilingnewimmunotherapypatentexclusiveotcpinktsoihtmtherapeutic solutions international announces filing of new immunotherapy patent and exclusive patent license agreement with subsidiary emvolio incoceanside camarketwired  april    therapeutics solutions international inc otc pink tsoi announced today the filing of a new patent and exclusive licensing agreement with majority owned subsidiary emvolio incthe patent describes methods of cancer treatment through the administrmarketwiredcomtherapeutic solutions international inc ·  · synergistic inhibition of b melanoma the following example demonstrates that pteros­tilbene in combination with il synergistically inhibits b melanoma in mice female cbl mice aged  weeks were purchased from the jackson laboratory a murine mela­noma cell line established from a cbl mouse and designated bf was obtained from the american type culture collection atcc and was maintained in rpmi  medium sigmaaldrich with  fbs glutamine peni⋯⋯cillin and streptomycin at ° c in  co the cell line was cultured at ° c in a  incubator for induction of tumor growth xl b cells were injected subcutaneously into the hind limb flank tumor growth was assessed every  days by two measure­ments of perpendicular diameters by a caliper and animals were sacrificed when tumors reached a size of  cm in any direction tumor volume was calculated by the following formula the shortest diameterxthe longest diameter mice treated represent  mice per group animals were treated every second day with group a saline diamonds b pterostilbene  µgkg squaresd c il  ivmouse trianglesfl and d a combination of il and pterostilbene at the indicated concentrations x as shown in fig  tumor growth is inhibited by the administration of the combination of  µgkg pterostilbene and  ivmouse il  therapeutic solutions international inc announces memorandum of understanding with zyppah inchomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  hrs  minssp  dow  nasdaq therapeutic solutions international inc announces memorandum of understanding with zyppah incmarketwiredaugust  reblogsharetweetshareoceanside camarketwired  aug     therapeutic solutions international inc  otcqb  tsoi  announced today a collaboration with zyppah inc in efforts to promote zyppahs professional education classes wherein tsis sleepwell® product will be included as a therapeutic option and recommendation for dentists attending zyppahs professional education classesuntil now most patients diagnosed with mild to moderate obstructive sleep apnea osa have been treated with a standard mandibular advancement device mad continuous positive airway pressure cpap machine or surgery said dr jonathan greenburg ceo of zyppah inc who also stated this agreement between zyppah and tsi to provide tsis sleepwell® product enhanced with the patentpending zyppah® elastic will offer dentists and their patients a new standard of treatment for both snoring and mild to moderate sleep apneadr barry glassman vice president of education and training said we have been truly impressed with the vision of dr jonathan greenburg and his team at zyppah and thrilled that tsi will be playing a key role not only in education but in future growth and decision making tsis sleepwell appliance has been added as a top level choice in the appliance armamentarium and i will be guiding the educational program there is no question that this association will benefit both zyppah and tsitim dixon ceo of tsi stated this agreement with zyppah and dr greenburg will help tsi to promote the awareness of sleepwell® within the professional dental community and will beneficially aid the sale of sleepwell hardware to licensed dentists and dental labs in the united statestherapeutic solutions international is also a global manufacturer of the chairside anterior midpoint stop appliance ampsa devices marketed internationally under the trade names migranx® and ampsa cs® which have helped countless patients prevent debilitating migraine and tension headache pain bruxism clenching grinding and tmj disorders the migranx® and ampsa cs® devices are the most effective nondrug us fda cleared dental method of migraine prevention on the market today therapeutic solutions international is the exclusive united states distributor of sleepwell™ hardware used to manufacture the sleepwell® dental appliance for snoring and mild to moderate obstructive sleep apneaabout zyppah inczyppah rx is an fdacleared selfmolded boilandbite oral appliance that is effective safe and easy to use product information can be viewed at wwwzyppahcomabout therapeutic solutions international incthe companys corporate website is wwwtherapeuticsolutionsintcom nonus dentists and physicians can order our ampsa products at wwwordertsoicom for the sleepwell® product clinical data can be viewed at wwwsleepwelldevicecomsafe harbor statement this release contains forwardlooking statements that are based upon current expectations or beliefs as well as a number of assumptions about future events although we believe that the expectations reflected in the forwardlooking statements and the assumptions upon which they are based are reasonable we can give no assurance that such expectations and assumptions will prove to have been correct forwardlooking statements are generally identifiable by the use of words like may will should could expect anticipate estimate believe intend or project or the negative of these words or other variations on these words or comparable terminology the reader is cautioned not to put undue reliance on these forwardlooking statements as these statements are subject to numerous risk factors as set forth in our sec filings to the extent that statements in this press release are not strictly historical including statements as to product launch timing revenue projections business strategy outlook objectives future milestones plans intentions goals future collaboration agreements or otherwise as to future events such statements are forwardlooking and are made pursuant to the safe harbor provisions of the private securities litigation reform act of  the forwardlooking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made readers are advised to review our filings with the securities and exchange commission that can be accessed over the internet at the secs website located at wwwsecgovreblogsharetweetsharerecently viewedyour list is emptywhat to read next people have canceled their tesla model  ordersbusiness insiderstart living the millionaire lifestyletoroptionsponsoreddont put that guy in front of the cameras again fox news host unloads on stephen miller after altercation with cnn reporterbusiness insiderthat doesnt just happen trump continues to boast about the stock marketyahoo financeif you want to lose weight this is how to structure your workoutpopsugar usmy fear is the us economy gets stuck in a low growth trap nyse traderyahoo finance videotesla delivers the spark investors wantedyahoo financethese are the greatest fears that people have in the worldbusiness insidera british volunteer fighting isis in syria reportedly killed himself to avoid being capturedbusiness insider of android users are less likely to switch to iphone due to headphone jackyahoo financeoprah winfrey keeps it real on weight loss explains why she cant accept herself weighing over  poundsentertainment tonightstocks are facing these headwinds at dow k nyse traderyahoo finance videohow to get one of the  jobs at amazonyahoo financefoxconn steers clear of trumps  billion investment claimassociated pressafter trying to build selfdriving tractors for more than  years john deere has learned a hard truth about autonomyquartzwall street opens flat as tech stocks slipreuterstrump set to embark on st vacation since inaugurationbill trump has played  rounds of golf already sounds like hes been on vacation since he took officejoin the conversation  k therapeutic solutions international inc signs distribution agreement with amalgadent dental supplies pty ltd australiahomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchskip to navigationskip to main contentskip to related contenttherapeutic solutions international inc signs distribution agreement with amalgadent dental supplies pty ltd australiamarketwireapril  reblogsharetweetsharesan diego camarketwire    therapeutic solutions international inc pinksheetstsoi  news pinksheetstsoi  news the only manufacturer of the chairside nti tension suppression system that has helped countless patients prevent debilitating migraine and tension headache pain announced today the signing of a sales and distribution agreement with amalgadent dental supplies pty ltd an australian dental supply company headquartered in caulfield south australiawe are very excited to sign this agreement with amalgadent stated tim dixon president of tsi as we begin to bring this innovative technology to markets around the world the agreement with amalgadent allows australian and new zealand dentists the ability to provide this unique chairside dental product to their patientswe have made our name in supplying niche dental products that supply simple solutions to previously complex problems directly to dentists said myer rozen of amalgadent for this reason the agreement with therapeutic solutions international inc is a perfect fit with our philosophy therapeutic solutions has products that demystify the areas of tmd and other sleep disorders of dental origin that previously required dentists to refer work to outside specialists with tsis products patients can be offered a much more convenient and time saving servicemr rozen also commented this is not only cost saving for the patient but keeps the practice income within the dental practice in these difficult economic times these cost effective solutions are of great value by keeping the treatment within the practice many patients are able to save expensive laboratory fees specialist fees and the time that other appointments take this enables people to be treated who may otherwise neglect their condition due to the inconvenience and expense we are excited to bring these solutions not only to dentists but to the benefit of their patientsabout amalgadent dental supplies pty ltdfirst established in melbourne victoria australia in  amalgadent is often described as australias most innovative supplier of niche  specialty professional dental products wwwamalgadentcomauabout therapeutic solutions international inctherapeutic solutions international inc is a company whose business plan is focused on the development production and marketing of cost effective technologies and therapeutic modalities for the treatment and prevention of common neurologic sleep and temporomandibular disorderstsi has several important websites to disseminate information and market their products our clinical research site for the nti is wwwntitsscom and our ecommerce portal is located at wwwordertsicom our patient education site located at wwwheadachepreventioncom and our corporate website for tsi is wwwtherapeuticsolutionsintcomsafe harbor statement this release contains forwardlooking statements that are based upon current expectations or beliefs as well as a number of assumptions about future events although we believe that the expectations reflected in the forwardlooking statements and the assumptions upon which they are based are reasonable we can give no assurance that such expectations and assumptions will prove to have been correct forwardlooking statements are generally identifiable by the use of words like may will should could expect anticipate estimate believe intend or project or the negative of these words or other variations on these words or comparable terminology the reader is cautioned not to put undue reliance on these forwardlooking statements as these statements are subject to numerous factors and uncertainties including but not limited to adverse economic conditions intense competition lack of meaningful research results entry of new competitors and products adverse federal state and local government regulation inadequate capital termination of contracts or agreements technological obsolescence of our products technical problems with our research and products price increases for supplies and components inability to carry out research development and commercialization plans loss or retirement of key executives and research scientists and other specific risks to the extent that statements in this press release are not strictly historical including statements as to revenue projections business strategy outlook objectives future milestones plans intentions goals future financial conditions future collaboration agreements the success of the companys development events conditioned on stockholder or other approval or otherwise as to future events such statements are forwardlooking and are made pursuant to the safe harbor provisions of the private securities litigation reform act of  the forwardlooking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made readers are advised to review our filings with the securities and exchange commission that can be accessed over the internet at the secs website located at httpwwwsecgovreblogsharetweetsharepopular in the communitythe obamas send newlywed couple a moving note of congratulations reactionsstart living the millionaire lifestyletoroptionsponsoredfire breaks out at worlds largest fish market in tokyo reactionstrump frustrated by afghan war suggests firing us commander officials reactionsdave chappelle says donald trump is like a ‘bad dj at a good party’ reactionselephant parade hits the streets of são paulo reactionshuckabee sanders takes a dig at sen flake over antitrump book reactionsluis fonsi on justin biebers spanish despacito hitting no  reactions people have canceled their tesla model  orders reactionsdeath of texas woman found buried on maryland beach ruled accidental reactionstrump set to embark on st vacation since inauguration reactionstraining with americas militias reactionsthe briefing room legal immigration reform reactionshistoric pearl river mart reopens to bring crosscultural joy to nyc reactionskendall jenner flashes underboob while out with bella hadid and hailey baldwin pics reactionsgame of throness sophie turner i got a job over a better actress because i had more followers reactionssarah huckabee sanders stephen miller put cnns jim acosta in his placebuster bloodvessel there isnt a single one in this administration that isnt a complete moronjoin the conversation